Risk of bleeding with single, dual, or triple therapy with warfarin, aspirin, and clopidogrel in patients with atrial fibrillation
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
Patients with atrial fibrillation (AF) often require anticoagulation and platelet inhibition, but data are limited on the bleeding risk of combination therapy.
| Originalsprog | Engelsk |
|---|---|
| Tidsskrift | Archives of Internal Medicine |
| Vol/bind | 170 |
| Udgave nummer | 16 |
| Sider (fra-til) | 1433-41 |
| Antal sider | 9 |
| ISSN | 0003-9926 |
| DOI | |
| Status | Udgivet - 13 sep. 2010 |
ID: 34044217